−5.87 MAUD
892.08 KAUD
1.68 M
About MEDLAB CLINICAL LIMITED
Medlab Clinical Ltd. is a biotechnology company, which engages in the development of nutraceutical products for chronic diseases and mental health conditions. It operates through the Nutraceutical and Pharmaceutical Research segments. The Pharmaceutical Research segment focuses on depression and oncology, and the supply of cannabis-based medicines. The company was founded by Sean Hall on June, 2012 and is headquartered in Perth, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MDC is 6.60 AUD — it has decreased by 4.21% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange MEDLAB CLINICAL LIMITED stocks are traded under the ticker MDC.
MEDLAB CLINICAL LIMITED is going to release the next earnings report on Aug 30, 2024. Keep track of upcoming events with our Earnings Calendar.
MDC stock is 4.39% volatile and has beta coefficient of −11.40. Check out the list of the most volatile stocks — is MEDLAB CLINICAL LIMITED there?
Yes, you can track MEDLAB CLINICAL LIMITED financials in yearly and quarterly reports right on TradingView.
Today MEDLAB CLINICAL LIMITED has the market capitalization of 15.07 M, it has decreased by 5.04% over the last week.
No, MDC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MDC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDLAB CLINICAL LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDLAB CLINICAL LIMITED technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDLAB CLINICAL LIMITED stock shows the sell signal. See more of MEDLAB CLINICAL LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.